Clinical Trials Logo

Filter by:
  • Withdrawn  
  • Page [1]
NCT ID: NCT01395381 Withdrawn - Kwashiorkor Clinical Trials

Effectiveness of Oral Albendazole in the Treatment of Severe Acute Malnutrition

Start date: January 2013
Phase: N/A
Study type: Interventional

The benefit of anti-worm therapy as part of the case management of severe acute malnutrition (SAM) in the outpatient setting has not previously been studied. This study will compare recovery rates of children with SAM treated in the community with locally-produced ready-to-use therapeutic food (RUTF) with and without prescribed albendazole as part of their case management.

NCT ID: NCT01337583 Withdrawn - HIV Infections Clinical Trials

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Start date: July 2011
Phase: Phase 3
Study type: Interventional

This is a double-blind, randomized, placebo-controlled Phase III study to asses the safety and efficacy of a silicone elastomer vaginal ring containing 25mg of dapivirine.

NCT ID: NCT01337570 Withdrawn - HIV Infections Clinical Trials

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Start date: July 2011
Phase: Phase 3
Study type: Interventional

This is a double-blind, randomized, placebo-controlled Phase III study to assess the safety and efficacy of a silicone elastomer vaginal ring containing 25mg of dapivirine.

NCT ID: NCT00998725 Withdrawn - Clinical trials for Unintended Pregnancy

Combined Oral Contraceptive (COC) Antiretroviral (ARV) Pharmacokinetics (PK) and Pharmacodynamics (PD) in Malawi

COCARVPK
Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of this research study is to learn about the birth control pill called LoFemenal in HIV+ and HIV negative women who live in Malawi. This is a pilot study to determine the effect of antiretroviral therapy on the pharmacokinetics of the most commonly used oral contraceptive in HIV+ women; and to measure ovulation suppression in women taking the oral contraceptive pill and antiretroviral therapy at the same time. Nine women will be enrolled and will be followed for a total of 4 months.